We investigated the effects of antiretroviral therapy (ART) on cholesterol biosynthesis in 25 a case-control study. mRNA and protein expressions of 3-hydroxy-3-methylglutaryl-26 coenzyme A reductase (HMGCR) and ATP binding cassette transporter A1 (ABCA1) 27
acidosis, peripheral neuropathies, cardiomyopathies, and pancytopenia 1-5 . In adults, MetS 48 is defined as having at least three out of five of the following components: impaired 49 fasting glucose or diabetes, hypertension, central obesity (increased waist circumference), 50 elevated triglycerides or reduced high-density lipoprotein (HDL) cholesterol 6 . The 51 prevalence of MetS in people living with HIV (PLWH) is as high as 83%, particularly in 52 PLWH on protease inhibitors (PI)-based regimens 7 , compared to 34% in the general 53 population 8 . MetS has been associated with an increased risk of cardiovascular diseases 54 (CVDs) such as myocardial infarction (MI), atherosclerosis, and stroke 9, 10 . 55
The high prevalence of MetS and CVDs in PLWH may be due to a complex 56 interplay of HIV infection 11, 12 , ART exposure, other viral co-infections 13, 14 , and 57 traditional risk factors such as genetic predisposition genetics 15 and lifestyle habits. 58
However, the underlying mechanisms are not well known. We recently observed that 59 CEM cells exposed to 1x and 4x the Cmax of various antiretroviral combinations resulted 60 in differential expressions of 122 out of 48,226 genes using microarray analysis 61 (published 16 and unpublished data). Over a third of those genes belonged to the 62 cholesterol biosynthesis pathway. Based on our findings, we hypothesized that ART 63 could perturb cholesterol biosynthesis genes before manifestation of overt signs and 64 symptoms of lipid abnormalities and MetS. We investigated the effect of ART on 65 cholesterol biosynthesis in peripheral blood mononuclear cells (PBMCs) of HIV 66 treatment-experienced individuals (cases) compared to HIV-negative healthy individuals 67
(controls). 68
We interrogated four major pathways genes involved in cholesterol regulation 69 using mRNA and protein expression studies: sensory control (sensor sterol regulatory 70 element binding protein 2, SREBP-2), de novo synthesis (3-hydroxy-3-methylglutaryl-71 coenzyme A reductase, HMGCR), cholesterol uptake (low-density lipoprotein receptor, 72 LDLR), and efflux (ATP binding cassette transporter A1, ABCA1). We also measured 73 the expression of AMP-activated protein kinase A1 & B2 (AMPK A1 & AMPK B2, 74 precursors of the cholesterol synthesis pathway. 75
Study participants were enrolled at the Yale-New Haven Hospital from April 76 2011 to March 2013. The details of the study design for the study cohort have been 77 described previously 17 . In brief, cases comprised HIV-infected individuals on ART for at 78 least 12 months without clinical and/or laboratory toxicities. Cases were matched HIV-79 negative controls. by age, sex, and race/ethnicity to HIV-negative controls. The study 80 protocol was approved by the Institutional Review Board of the Yale School of Medicine. 81
All participants gave their written informed consent before participation in the study. 82
The cholesterol sub-study, included only study participants with sufficient 83 archived PBMCs for the analysis (cases, n=18, and controls, n=18). We extracted RNA 84 and proteins from PBMCs for mRNA expression and protein expression, respectively, of 85 cholesterol biosynthesis pathway genes. We report data as medians with interquartile 86 ranges (unless otherwise stated) and as frequencies with percentages for continuous and 87 categorical variables, respectively. We used Wilcoxon signed-rank test to compare 88 continuous variables and Pearson correlation to examine bivariate associations. P-values 89 were considered significant if <0.05. All statistical analyses were performed using 90
GraphPad Prism software. 91 5
The demographic and clinical characteristics of study participants are illustrated 92
in Table 1 . The mean age was 52 years (range, 30 to 72 years), with 67% being males. 93
The ethnicity comprised 28% Non-Hispanic whites, 6% Hispanic white and 66% African 94
Americans. The ART regimen of the cohort was mostly tenofovir/emtricitabine (33%) 95 plus PI or integrase inhibitor, tenofovir/emtricitabine/efavirenz (50%) and 96 zidovudine/lamivudine (17%). 97
We quantified the mRNA expression of genes using qRT-PCR (supplementary 98 Table 1 for primer sets of the genes). Data was obtained from duplicate assays performed 99 on at least two different occasions. The fold change in gene expression was calculated 100 using the formula 2 ΔCT (Ref), where ΔCT(case) = (CT(gene of interest) − CT(GAPDH)), and 101 ΔCT(healthy control) = (CT(gene of interest) − CT(GAPDH)). mRNA expressions of HMGCR and 102 ABCA1 were upregulated in cases compared to controls (p=0.03 and p<0.01, 103 respectively) ( Figure 1 ). There was no significant difference in SREBP-2 expression 104 among cases and controls, although cases tended to have a lower expression of SREBP-2 105 and AMPK B2 compared to controls (Figure 1) . 106
With the significant increase in mRNA expressions of HMGCR and ABCA1 in 107 cases, we investigated whether this translated to protein expressions. Western blot 108 analysis was performed as described previously 18 using tubulin as the housekeeping gene. 109
The Western blot analysis was conducted on 16 participants with sufficient samples 110 (cases n=8 and controls n=8). The density of the bands was quantified suing Quantity 111 One Analysis Software. We observed a corresponding increase in protein expressions of 112 6
In health, there is a positive correlation between SREBP-2 and HMGCR as well 114 as SREBP-2 and LDLR 19, 20 . Therefore, with differential upregulation of HMGCR and 115 ABCA1 in cases and controls, we investigated the correlation between SREBP-2 and 116 HMGCR, and SREBP-2 and LDLR. As expected in controls (N=18), there was a 117 positive correlation between SREBP-2 and HMGCR (R 2 =0.24, p=0.04), and LDLR 118 (R 2 =0.23, p=0.05) (Figure 3) . To our surprise, the correlations among the cases were 119 negative ( Figure 3) . mean viral load of our cases was 23 (range, 20-79) copies/mL (Table 1) . Therefore, the 140 effect of HIV Nef protein may not play a significant role in our cohort. We expected that 141
ART will normalize expression of ABCA1, however, there was upregulation of ABCA1 142 in cases. The mean duration of therapy among cases was 4.77 (range, 1-7.5) years. Is it 143 plausible that the continued exposure to ART in our cohort led to upregulation of 144
ABCA1? 145
It is also interesting that we found an upregulation in the expressions of HMGCR 146 mRNA and protein; this is counterintuitive with upregulation of ABCA1. A plausible 147 explanation is that the upregulation of HMGCR was the inciting event that resulted in 148 intracellular cholesterol accumulation. Thus, the cell, in an attempt to restore 149 homeostasis, increases the expression of ABCA1. Another possible explanation could be 150 that there is dysregulation of cholesterol biosynthesis. We cannot tease out this 151 conundrum without intracellular cholesterol levels. However, the serum levels of 152 cholesterol in cases was within normal range implying the increase in ABCA1 is not 153 translating to increased efflux from the cell (Table 1) . 154
In the absence of intracellular cholesterol data, did a correlation analysis of 155 mRNA expression of cholesterol biosynthesis genes. We observed a normal association 156 of genes involved with cholesterol sensing-SREBP-2, HMGCR and LDLR in controls 157 ( Figure 2 ). In cases, there was negative correlation between SREBP-2 and HMGCR or 158 LDLR (Figure 2) . In health, SREBP-2 senses intracellular cholesterol levels and 159 8 upregulates cholesterol synthesis via HMGCR and uptake from the extracellular 160 environment via LDL receptors (LDLR) 33, 34 . Our finding suggests a dysregulation of 161 cholesterol biosynthesis, particularly sensing by SREBP-2 in cases. 162
Although, our study is one of the first studies to report potential dysregulation of 163 cholesterol biosynthesis in HIV treatment-experienced individuals, it has several 164 limitations. First, it is a cross-sectional study and not designed to assess causality. 165
Second, it was an exploratory pilot sub-study with small sample size to test and generate 166
hypotheses. Third, we did not quantify intracellular cholesterol levels to assess the effect 167 of intracellular cholesterol on the genes studied. Fourth, the effect of HIV infection itself, 168 say through HIV Nef protein, was not assessed since we did not have access to HIV 
